Solid Biosciences shares rise 2.81% after-hours following Anixa Biosciences' patent extension to 2045.

Solid Biosciences Inc. rose 2.81% in after-hours trading, following the issuance of a new patent by Anixa Biosciences, Inc. that extends the protection of its proprietary solid tumor CAR-T platform to 2045. This development is expected to enhance the company's competitive position in the biotechnology sector.